老年骨质疏松与维生素D研究进展
A Review of Osteoporosis and Vitamin D in the Elderly
DOI: 10.12677/ACM.2018.82024, PDF,  被引量   
作者: 代 敏:青岛大学,山东 青岛;贾秀娟:青岛大学附属医院,山东 青岛
关键词: 老年骨质疏松症维生素DElderly Osteoporosis Vitamin D
摘要: 随着我国人口老龄化的家中,老年人特有疾病的发病率呈上升趋势。其中一种疾病是骨质疏松症。骨质疏松症的真正发病率是未知的,但是估计表明,这种疾病影响着很大比例的人口,骨折是骨疏松最严重的后果之一,特别是在老年人群中。髋部骨折可能是毁灭性的,这对医疗保健系统造成了重大负担,因此可以预防或治疗这种疾病的干预措施成为临床研究的重点。维生素D是骨骼健康的重要组成部分,已在临床研究中作为治疗骨质疏松症的药物进行了测试。尽管取得了进展,但仍有一些关于维生素D的目标血液水平,补充该维生素的最有效方式以及该补充剂在老年人中的临床效果的一些争论。在本综述中,我们将重点介绍维生素D的代谢和维生素D与老年骨质疏松的关系。
Abstract: With the increase of the average age of our population, the incidence of diseases specific for older adults has been increasing. One of such diseases is osteoporosis. The actual incidence of osteopo-rosis is unknown. But the estimates suggest that this disease affects wide proportion of the popu-lation and that fractures are one of the most serious consequences of osteoporosis, especially in the elderly population. Hip fractures can be devastating, which places a significant burden on the healthcare system. So interventions that can prevent or treat the disease have become the focus of clinical research. Vitamin D is an important component of bone health and has been tested in clin-ical studies as a drug for the treatment of osteoporosis. Despite advances, there are still some de-bates about the target blood levels of vitamin D, the most effective way to supplement the vitamins, and the clinical effects of the supplements in the elderly. In this review, we will focus on the me-tabolism of vitamin D and the relationship between vitamin D and senile osteoporosis.
文章引用:代敏, 贾秀娟. 老年骨质疏松与维生素D研究进展[J]. 临床医学进展, 2018, 8(2): 141-147. https://doi.org/10.12677/ACM.2018.82024

参考文献

[1] Kanis, J.A., McCloskey, E.V., Johansson, E., et al. (2008) A Reference Standard for the Description of Osteoporosis. Bone, 42, 467-475.
[Google Scholar] [CrossRef] [PubMed]
[2] Center, J.R., Nguyen, T.V., Schneider, D., et al. (1999) Mortality after All Major Types of Osteoporotic Fracture in Men and Women: An Observational Study. Lancet, 353, 878.
[Google Scholar] [CrossRef
[3] Silverman, S. and Christiansen, C. (2012) Individualizing Osteoporosis Therapy. Osteoporosis International, 23, 797-809.
[Google Scholar] [CrossRef] [PubMed]
[4] Lin, J.T. and Lane, J.M. (2006) Rehabilitation of the Older Adult with an Osteoporosis-Related Fracture. Clinics in Geriatric Medicine, 22, 435-447
[Google Scholar] [CrossRef] [PubMed]
[5] Rapp, K., Rothenbacher, D., Magaziner, J., et al. (2015) Risk of Nursing Home Admission after Femoral Fracture Compared with Stroke, Myocardial Infarction, and Pneumonia. Journal of the American Medical Directors Association, 16, 715.e7-12.
[Google Scholar] [CrossRef] [PubMed]
[6] Khosla, S. (2001) Minireview: The OPG/RANKL/RANK Sys-tem. Endocrinology, 142, 5050-5055.
[Google Scholar] [CrossRef] [PubMed]
[7] Khosla, S., Melton 3rd, L.J., Riggs, B.L., et al. (2010) The Unitary Model for Estrogen Deficiency and the Pathogenesis of Osteoporosis: Is a Revision Needed? Journal of Bone and Mineral Research, 26, 441-451.
[Google Scholar] [CrossRef] [PubMed]
[8] Lim, S.Y. and Bolster, M.B. (2015) Current Approaches to Osteoporosis Treatment. Current Opinion in Rheumatology, 27, 216-224.
[Google Scholar] [CrossRef
[9] Duque, G. and Troen, B.R. (2008) Understanding the Mechanisms of Senile Osteoporosis: New Facts for a Major Geriatric Syndrome. Journal of the American Geriatrics Society, 56, 935-941.
[Google Scholar] [CrossRef] [PubMed]
[10] Kiebzak, G.M., Beinart, G.A., Perser, K., et al. (2002) Undertreatment of Osteoporosis in Men with Hip Fractures. Archives of Internal Medicine, 162, 2217-2222.
[Google Scholar] [CrossRef] [PubMed]
[11] Feldstein, A.C., Nichols, G., Orwoll, E., et al. (2005) The Near Absence of Osteoporosis Treatment in Older Men with Fractures. Osteoporosis International, 16, 953-962.
[Google Scholar] [CrossRef] [PubMed]
[12] Abbasi, A.A., Rudman, D., Wilson, C.R., et al. (1995) Observa-tions on Nursing Home Patient with History of Hip Fracture. The American Journal of the Medical Sciences, 310, 229-234.
[13] Ebeling, P.R. (2008) Osteoporosis in Men. The New England Journal of Medicine, 358, 1474-1482.
[Google Scholar] [CrossRef
[14] Behre, H., Kliesch, S., Leifke, E., et al. (1997) Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism, 82, 2386-2390.
[Google Scholar] [CrossRef] [PubMed]
[15] Webb, A.R., Kline, L. and Holick, M.F. (1988) Influence of Season and Latitude on the Cutaneous Synthesis of Vitamin D3: Exposure to Winter Sunlight in Boston and Edmonton Will Not Promote Vitamin D3 Synthesis in Human Skin. Journal of Clinical Endocrinology & Metabolism, 67, 373-378.
[Google Scholar] [CrossRef] [PubMed]
[16] Papaioannou, A., Santesso, N., Morin, S.N., et al. (2015) Recom-mendations for Preventing Fracture in Long-Term Care. Canadian Medical Association Journal, 187, 1135-1144.
[Google Scholar] [CrossRef] [PubMed]
[17] Dong, C.H., Gao, Q.M., Wang, Z.M., et al. (2016) Vitamin D Sup-plementation for Osteoporosis in Older Adults: Can We Make It Help Better? European Review for Medical & Phar-macological Sciences, 20, 4612-4621.
[18] Holick, M.F. (1987) Photosynthesis of Vitamin D in the Skin: Effect of Environmental and Life-Style Variables. Federation Proceedings, 46, 1876-1882.
[19] Miller, W.L. (2017) Genetic Disorders of Vitamin D Biosynthesis and Degradation. The Journal of Steroid Biochemistry and Molecular Biology, 165, 101-108.
[Google Scholar] [CrossRef] [PubMed]
[20] Holick, M.F. (2007) Vitamin D Deficiency. Ne-derlands Tijdschrift Voor Geneeskunde, 150, 1315-1316.
[Google Scholar] [CrossRef
[21] Baeke, F., Takiishi, T., Korf, H., et al. (2010) Vitamin D: Modulator of the Immune System. Current Opinion in Pharmacology, 10, 482-496.
[Google Scholar] [CrossRef] [PubMed]
[22] Mocanu, V. and Vieth, R. (2013) Three-Year Follow-Up of Se-rum 25-Hydroxyvitamin D, Parathyroid Hormone, and Bone Mineral Density in Nursing Home Residents Who Had Received 12 Months of Daily Bread Fortification with 125 μg of Vitamin D3. Nutrition Journal, 12, 137.
[Google Scholar] [CrossRef] [PubMed]
[23] Abboud, M., Gordon-Thomson, C., Hoy, A.J., et al. (2014) Up-take of 25-Hydroxyvitamin D by Muscle and Fat Cells. Journal of Steroid Biochemistry & Molecular Biology, 144, 232-236.
[Google Scholar] [CrossRef] [PubMed]
[24] Chun, R.F., Peercy, B.E., Adams, J.S., et al. (2012) Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling. PLoS ONE, 7, e30773.
[Google Scholar] [CrossRef] [PubMed]
[25] Trochoutsou, A.I., Kloukina, V., Samitas, K., et al. (2015) Vitamin-D in the Immune System: Genomic and Non-Genomic Actions. Mini Reviews in Medicinal Chemistry, 15, 953-963.
[Google Scholar] [CrossRef] [PubMed]
[26] Haussler, M.R., Jurutka, P.W., Mizwicki, M., et al. (2011) Vitamin D Receptor (VDR)-Mediated Actions of 1α,25(OH)₂ Vitamin D₃: Genomic and Non-Genomic Mech-anisms. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 543-559.
[Google Scholar] [CrossRef] [PubMed]
[27] Ross, A.C., Taylor, C.L., Yaktine, A.L., et al. (2012) Overview of Calcium-Dietary Reference Intakes for Calcium and Vitamin D—NCBI Bookshelf. Pediatrics, 130, 1427.
[28] Holick, M.F., Binkley, N.C., Bischoffferrari, H.A., et al. (2011) Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Me-tabolism, 96, 1911-1930.
[Google Scholar] [CrossRef] [PubMed]
[29] Rosen, C.J., Abrams, S.A., Aloia, J.F., et al. (2012) IOM Committee Members Respond to Endocrine Society Vitamin D Guideline. Obstetrical & Gynecological Survey, 67, 1146-1152.
[30] Boonen, S., Bischoffferrari, H.A., Cooper, C., et al. (2006) Addressing the Musculoskel-etal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence. Calcified Tissue International, 78, 257-270.
[Google Scholar] [CrossRef] [PubMed]
[31] Karasik, D., Rivadeneira, F. and Johnson, M.L. (2016) The Ge-netics of Bone Mass and Susceptibility to Bone Diseases. Nature Reviews Rheumatology, 12, 323-334.
[Google Scholar] [CrossRef] [PubMed]
[32] Mori, S. and Zhou, H. (2016) Implementation of Personalized Medicine for Fracture Risk Assessment in Osteoporosis. Geriatrics & Gerontology International, 16, 57-65.
[Google Scholar] [CrossRef] [PubMed]
[33] Pattanaungkul, S., Riggs, B.L., Yergey, A.L., et al. (2000) Relationship of Intestinal Calcium Absorption to 1,25-Dihydroxy Vitamin D [1,25(OH)2D] Levels in Young versus Elderly Women: Evidence for Age-Related Intestinal Resistance to 1,25(OH)2D Action. The Journal of Clinical Endocrinology & Me-tabolism, 85, 4023-4027.
[Google Scholar] [CrossRef] [PubMed]
[34] Eisman, J.A. and Bouillon, R. (2014) Vitamin D: Direct Effects of Vitamin D Metabolites on Bone: Lessons from Genetically Modified Mice. Bonekey Reports, 3, 499.
[Google Scholar] [CrossRef] [PubMed]
[35] Friedman, H.Z., Langman, C.B. and Favus, M.J. (1985) Vitamin D Metabolism and Osteomalacia in Cystic Fibrosis. Gastroenterology, 88, 808-813.
[Google Scholar] [CrossRef] [PubMed]
[36] Nelson, J.E., Roth, C.L., Wilson, L., et al. (2016) Vitamin D Deficiency Is Associated with Increased Risk of Nonalcoholic Steatohepatitis in Adults with Nonalcoholic Fatty Liver Disease: Possible Role for MAPK and NF-kB? American Journal of Gastroenterology, 111, 852-863.
[Google Scholar] [CrossRef] [PubMed]
[37] Dusilovásulková, S., Šafránek, R., Vávrová, J., et al. (2015) Low-Dose Cholecalciferol Supplementation and Dual Vitamin D Therapy in Haemodialysis Patients. International Urology & Nephrology, 47, 169-176.
[Google Scholar] [CrossRef] [PubMed]
[38] 李锦军, 陈浩, 唐海, 等. 老年骨质疏松人群维生素D缺乏与跌倒风险关系的研究[J]. 临床和实验医学杂志, 2017, 16(5): 482-485.